Diagnosis of cystic fibrosis

Clinical Reviews in Allergy and Immunology

Volumn 35, Issue 3, 2008, Pages 100-106

  Voter, Karen Z ^a   Ren, Clement L ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

CFTR; Cystic fibrosis; Genetic disease; Pancreatic insufficiency; Sinusitis; Sweat testing

Indexed keywords

CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AUTOSOMAL RECESSIVE DISORDER; BRONCHITIS; CLINICAL FEATURE; CYSTIC FIBROSIS; FALSE POSITIVE RESULT; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; ION TRANSPORT; IONTOPHORESIS; LIVE BIRTH; MUCUS SECRETION; NEWBORN SCREENING; NOSE POLYP; PANCREAS INSUFFICIENCY; PHENOTYPE; POTENTIAL DIFFERENCE; PREVALENCE; REVIEW; SINUSITIS; SWEAT GLAND; SWEAT TEST; UNITED STATES; BRONCHIECTASIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MUTATION; NUCLEOTIDE SEQUENCE; PANCREAS EXOCRINE INSUFFICIENCY; PATHOPHYSIOLOGY; RECESSIVE GENE; SWEATING;

BRONCHIECTASIS; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DNA MUTATIONAL ANALYSIS; EXOCRINE PANCREATIC INSUFFICIENCY; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION; SWEATING;

EID: 59449100259     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-008-8078-x     Document Type: Review

References (31)

1. PB Davis M Drumm MW Konstan 1996 Cystic fibrosis Am J Respir Crit Care Med 154 1229 1256
2. National Newborn Screening and Genetics Resource Center (2003) National newborn screening report 2000. National Newborn Screening and Genetics Resource Center, San Antonio, TX
3. D Andersen 1938 Cystic fibrosis of the pandrease and its relation to celiac disease: a clinical and pathological study Am J Dis Child 56 344 399
4. P Di Sant'Agnese 2001
5. LE Gibson RE Cooke 1959 A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis Pediatrics 23 545 549
6. BJ Rosenstein GR Cutting 1998 The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel J Pediatr 132 589 595
7. JR Riordan JM Rommens B Kerem N Alon R Rozmahel Z Grzelczak 1989 Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 245 1066 1073
8. RK Rowntree A Harris 2003 The phenotypic consequences of CFTR mutations Ann Hum Genet 67 471 485
9. PB Davis 2001 Cystic fibrosis Pediatr Rev 22 257 264
10. Cystic Fibrosis Foundation (2006) Cystic fibrosis foundation patient registry. Cystic Fibrosis Foundation, Bethesda, MD
11. H Matsui BR Grubb R Tarran SH Randell JT Gatzy CW Davis 1998 Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease Cell 95 1005 1015
12. JJ Wine 1999 The genesis of cystic fibrosis lung disease J Clin Invest 103 309 312
13. F Ratjen 2006 Restoring airway surface liquid in cystic fibrosis N Engl J Med 354 291 293
14. VA LeGrys JR Yankaskas LM Quittell BC Marshall PJ Mogayzel Jr 2007 Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines J Pediatr 151 85 89
15. NCCLS (2000) Sweat testing: sample collection and quantitative analysis: approved guideline. National Committee for Clinical Laboratory Standards, Wayne, PA Document C34-A2. Clinical Laboratory Standards Institute formerly National Committee for Clinical Laboratory Standards
16. SD Grosse CA Boyle JR Botkin AM Comeau M Kharrazi M Rosenfeld 2004 Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs MMWR Recomm Rep 53 1 36
17. MR Knowles PR Durie 2002 What is cystic fibrosis? N Engl J Med 347 439 442
18. K De Boeck M Wilschanski C Castellani C Taylor H Cuppens J Dodge 2006 Cystic fibrosis: terminology and diagnostic algorithms Thorax 61 627 635
19. PL Zeitlin 1999 Novel pharmacologic therapies for cystic fibrosis J Clin Invest 103 447 452
20. SH Donaldson RC Boucher 2007 Sodium channels and cystic fibrosis Chest 132 1631 1636
21. A Hamosh SC FitzSimmons M Macek Jr. MR Knowles BJ Rosenstein GR Cutting 1998 Comparison of the clinical manifestations of cystic fibrosis in black and white patients J Pediatr 132 255 259
22. JJ Wine E Kuo G Hurlock RB Moss 2001 Comprehensive mutation screening in a cystic fibrosis center Pediatrics 107 280 286
23. H Cuppens W Lin M Jaspers B Costes H Teng A Vankeerberghen 1998 Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation J Clin Invest 101 487 496
24. DN Sheppard DP Rich LS Ostedgaard RJ Gregory AE Smith MJ Welsh 1993 Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties Nature 362 160 164
25. BP O'Sullivan RG Zwerdling HL Dorkin AM Comeau R Parad 2006 Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype Pediatrics 118 1260 1265
26. CL Ren 2007 Pulmonary manifestations in deltaF508/R117H Pediatrics 119 647 648
27. WE Highsmith LH Burch Z Zhou JC Olsen TE Boat A Spock 1994 A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations N Engl J Med 331 974 980
28. EW Alton D Currie R Logan-Sinclair JO Warner ME Hodson DM Geddes 1990 Nasal potential difference: a clinical diagnostic test for cystic fibrosis Eur Respir J 3 922 926
29. MR Knowles AM Paradiso RC Boucher 1995 In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis Hum Gene Ther 6 445 455
30. RA Sauder SE Chesrown GM Loughlin 1987 Clinical application of transepithelial potential difference measurements in cystic fibrosis J Pediatr 111 353 358
31. JS Wagener MK Sontag FJ Accurso 2003 Newborn screening for cystic fibrosis Curr Opin Pediatr 15 309 315